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Kdm5 demethylases are crucial for the coordination of gene expression programs across different developmental contexts [14] . More recently, their important functions during oogenesis have begun to be uncovered. We and others have shown that Drosophila Kdm5 restricts the levels of H3K4me3 in developing female germ cells and is required both for synaptonemal complex assembly and the temporal control of gene expression during meiosis [15, 16] . Such functions highlight the role of these enzymes as potent chromatin remodelers during female gametogenesis, which is further illustrated by the significant defects in meiotic and postmeiotic chromosome architecture observed in Kdm5-depleted oocytes [15, 16] . Not surprisingly, the loss of Kdm5 and its demethylase activity are associated with a significant reduction of female fertility [15] . Now Torres-Campana and colleagues [5] further expand the gamut of Kdm5-related functions during oogenesis to include the transcriptional regulation of deadhead (dhd)-a major player in the oocyte-to-zygote transition. dhd encodes a thioredoxin-like protein that was previously described to be essential for sperm chromatin decompaction after fertilization [17] . The authors observed that dhd expression was severely reduced in Kdm5-depleted oocytes [5] , which is in accordance with their recorded incapability of forming the paternal pronucleus. Importantly, Kdm5 depletion was associated with a sharp decrease of H3K4me3 across the dhd gene body, suggesting that Kdm5 directly regulates dhd expression. Although this counterintuitive loss of H3K4me3 after depletion of a histone demethylase would favor a demethylase-independent function of Kdm5, this does not seem to be the case. In fact, in a rather surprising twist of events, a demethylase-inactive allele of Kdm5 failed to rescue dhd expression levels in Kdm5-depleted oocytes.
How can we reconcile the seemingly contradictory observations that Kdm5 demethylase activity is required for dhd expression but the absence of Kdm5 is in itself associated with low levels of H3K4me3 in dhd? Two nonmutually exclusive hypotheses can be envisaged. In the first, Kdm5 regulates H3K4me3 levels in a yet unknown enhancer sequence responsible for the control of dhd expression. In the second, a specific Kdm5-mediated organization of germ-cell chromatin architecture may be required for the efficient expression of dhd. Under this hypothesis, we can posit a scenario where Kdm5 depletion impairs the organization of topologically associating domains (TADs) due to increased H3K4me3 and/or reduced activity of Kdm5-interacting partners (such as the SIN3 histone deacetylase complex).
An important point from Torres-Campana and colleagues' study [5] regards the experiment in which the authors attempt to suppress, via ectopic expression of dhd, the sperm chromatin-remodeling defects of Kdm5-depleted oocytes. The outcome of this experiment was a quite modest degree of functional rescue, which clearly suggests that besides dhd, Kdm5 regulates the expression of other genes similarly important for postfertilization development. Such observation parallels our previous results on the mixed-lineage leukemia 3/4 (MLL3/4) histone methyltransferase [known in Drosophila as dMLL3/4 or trithorax-related (Trr)], in which we could demonstrate that the activity of this chromatin remodeler during oogenesis promoted the expression of a subset of genes later required for different aspects of the oocyte-to-zygote transition [4] . Quite significantly, the loss of this methyltransferase was associated with a broad palette of oocyte activation defects, such as the incapability of completing meiosis, forming the paternal pronucleus, and initiating the embryonic mitotic divisions.
Collectively, these studies emphasize the point that transcriptional regulation during oogenesis prepares the oocyte for activation (Fig 1) . We can thus hypothesize that different epigenetically defined gene expression modules establish, as the oocyte develops, the molecular basis of the future oocyte-to-zygote transition. In this regard, it is important to mention that the disruption of histone demethylases during mouse oogenesis [including lysine-specific demethylase 5B (Kdm5b)] has also been associated with meiotic defects and female infertility [18] . It is therefore likely that some of the key molecular players responsible for orchestrating oocyte maturation and the oocyte-to-zygote transition are evolutionarily conserved between Drosophila and mammals. Accordingly, exploring the role of chromatin-remodeling enzymes such as Kdm5 in the context of human fertility represents an exciting and still clinically underexplored topic.
